Tevogen Bio Holdings Stock Analysis

TVGN Stock   1.24  0.10  8.77%   
Tevogen Bio Holdings is overvalued with Real Value of 1.09 and Target Price of 4.2. The main objective of Tevogen Bio stock analysis is to determine its intrinsic value, which is an estimate of what Tevogen Bio Holdings is worth, separate from its market price. There are two main types of Tevogen Bio's stock analysis: fundamental analysis and technical analysis.
The Tevogen Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Tevogen Bio is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Tevogen Stock trading window is adjusted to America/New York timezone.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Tevogen Stock Analysis Notes

About 91.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. To find out more about Tevogen Bio Holdings contact MPH MD at 877 838 6436 or learn more at https://tevogen.com.

Tevogen Bio Holdings Investment Alerts

Tevogen Bio Holdings is way too risky over 90 days horizon
Tevogen Bio Holdings may become a speculative penny stock
Tevogen Bio Holdings appears to be risky and price may revert if volatility continues
Net Loss for the year was (67.33 K) with profit before overhead, payroll, taxes, and interest of 0.
Tevogen Bio generates negative cash flow from operations
About 91.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Disposition of 232968 shares by Flomenberg Neal of Tevogen Bio at 1.09 subject to Rule 16b-3

Tevogen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 217.06 M.

Tevogen Profitablity

Last ReportedProjected for Next Year
Return On Equity 0.10  0.11 

Management Efficiency

Tevogen Bio Holdings has return on total asset (ROA) of (5.4218) % which means that it has lost $5.4218 on every $100 spent on assets. This is way below average. Tevogen Bio's management efficiency ratios could be used to measure how well Tevogen Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of March 2025, Return On Equity is likely to grow to 0.11, while Return On Tangible Assets are likely to drop (0). As of the 25th of March 2025, Total Assets is likely to drop to about 18.6 M. In addition to that, Non Current Assets Total is likely to drop to about 18.2 M
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA8.8 K9.2 K
Price Book Value Ratio-3 K-2.9 K
Enterprise Value Multiple8.8 K9.2 K
Price Fair Value-3 K-2.9 K
Enterprise Value1.7 B1.2 B
At Tevogen Bio Holdings, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Beta
(1.05)
Return On Assets
(5.42)

Technical Drivers

As of the 25th of March, Tevogen Bio has the Risk Adjusted Performance of 0.077, semi deviation of 6.12, and Coefficient Of Variation of 1322.74. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tevogen Bio Holdings, as well as the relationship between them.

Tevogen Bio Holdings Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tevogen Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tevogen Bio Holdings. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Tevogen Bio Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tevogen Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tevogen Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tevogen Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Tevogen Bio Outstanding Bonds

Tevogen Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tevogen Bio Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tevogen bonds can be classified according to their maturity, which is the date when Tevogen Bio Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Tevogen Bio Predictive Daily Indicators

Tevogen Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tevogen Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Tevogen Bio Forecast Models

Tevogen Bio's time-series forecasting models are one of many Tevogen Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tevogen Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Tevogen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tevogen Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tevogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tevogen Bio. By using and applying Tevogen Stock analysis, traders can create a robust methodology for identifying Tevogen entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Tevogen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tevogen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tevogen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.2Strong Sell0Odds
Tevogen Bio Holdings current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Tevogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Tevogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Tevogen Bio Holdings, talking to its executives and customers, or listening to Tevogen conference calls.
Tevogen Analyst Advice Details

Tevogen Stock Analysis Indicators

Tevogen Bio Holdings stock analysis indicators help investors evaluate how Tevogen Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tevogen Bio shares will generate the highest return on investment. By understating and applying Tevogen Bio stock analysis, traders can identify Tevogen Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow129.2 K
Common Stock Shares Outstanding165.4 M
Total Stockholder Equity-695.8 K
Property Plant And Equipment Net928.5 K
Cash And Short Term Investments8835.00
Cash8835.00
Accounts Payable1.1 M
Net Debt1.6 M
50 Day M A1.3343
Total Current LiabilitiesM
Other Operating Expenses2.3 M
Non Current Assets Total16.7 M
Non Currrent Assets Other-928.5 K
When determining whether Tevogen Bio Holdings is a strong investment it is important to analyze Tevogen Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tevogen Bio's future performance. For an informed investment choice regarding Tevogen Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.35
Return On Assets
(5.42)
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.